[go: up one dir, main page]

FR2953522B1 - Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques - Google Patents

Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques

Info

Publication number
FR2953522B1
FR2953522B1 FR0958689A FR0958689A FR2953522B1 FR 2953522 B1 FR2953522 B1 FR 2953522B1 FR 0958689 A FR0958689 A FR 0958689A FR 0958689 A FR0958689 A FR 0958689A FR 2953522 B1 FR2953522 B1 FR 2953522B1
Authority
FR
France
Prior art keywords
octasulfates
pharmaceutical
preparation
cosmetic applications
sucrose zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0958689A
Other languages
English (en)
Other versions
FR2953522A1 (fr
Inventor
Pierre Fabre
Severine Jeulin
Marion Kopec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0958689A priority Critical patent/FR2953522B1/fr
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Priority to JP2012542475A priority patent/JP2013512938A/ja
Priority to US13/514,121 priority patent/US20120245120A1/en
Priority to PCT/EP2010/068873 priority patent/WO2011069921A1/fr
Priority to EP10795975A priority patent/EP2509989A1/fr
Priority to TW099142344A priority patent/TW201127388A/zh
Priority to ARP100104511A priority patent/AR079312A1/es
Publication of FR2953522A1 publication Critical patent/FR2953522A1/fr
Application granted granted Critical
Publication of FR2953522B1 publication Critical patent/FR2953522B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
FR0958689A 2009-12-07 2009-12-07 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques Expired - Fee Related FR2953522B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0958689A FR2953522B1 (fr) 2009-12-07 2009-12-07 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
US13/514,121 US20120245120A1 (en) 2009-12-07 2010-12-03 Zinc sucrose octasulfates, their preparation, and pharmaceutical and cosmetic uses thereof
PCT/EP2010/068873 WO2011069921A1 (fr) 2009-12-07 2010-12-03 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
EP10795975A EP2509989A1 (fr) 2009-12-07 2010-12-03 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
JP2012542475A JP2013512938A (ja) 2009-12-07 2010-12-03 ショ糖オクタ硫酸エステル亜鉛塩、それらの製造、ならびにその医薬品および化粧品用途
TW099142344A TW201127388A (en) 2009-12-07 2010-12-06 Zinc sucrose octasulfates, their preparation and pharmaceutical and cosmetic uses thereof
ARP100104511A AR079312A1 (es) 2009-12-07 2010-12-07 Octasulfatos de sacarosa de zinc, su preparacion y sus usos farmaceuticos y cosmeticos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958689A FR2953522B1 (fr) 2009-12-07 2009-12-07 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques

Publications (2)

Publication Number Publication Date
FR2953522A1 FR2953522A1 (fr) 2011-06-10
FR2953522B1 true FR2953522B1 (fr) 2012-03-09

Family

ID=42044412

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0958689A Expired - Fee Related FR2953522B1 (fr) 2009-12-07 2009-12-07 Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques

Country Status (7)

Country Link
US (1) US20120245120A1 (fr)
EP (1) EP2509989A1 (fr)
JP (1) JP2013512938A (fr)
AR (1) AR079312A1 (fr)
FR (1) FR2953522B1 (fr)
TW (1) TW201127388A (fr)
WO (1) WO2011069921A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2977797B1 (fr) * 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
FR2977798B1 (fr) * 2011-07-13 2016-07-29 Urgo Lab Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques
EP2793845A4 (fr) * 2011-12-21 2016-02-24 Colgate Palmolive Co Procédés et produits pour diagnostiquer et traiter un excès de chaleur (« heatiness »)
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr) 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
CN103193835B (zh) * 2013-04-18 2015-06-24 安徽赛诺制药有限公司 一种蔗糖八磺酸酯钠合成及纯化的方法
CN114436858A (zh) * 2020-11-03 2022-05-06 江苏开元药业有限公司 一种药用辅料的三乙胺盐的制备方法
CN116063360A (zh) * 2022-09-22 2023-05-05 麦吉丽生物科技有限公司 用于改善皮肤功能的二糖聚硫酸盐及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1390007A (fr) 1964-04-13 1965-02-19 Plage permettant d'intégrer sur un disque un enregistrement publicitaire ou autre
ZA869530B (en) * 1985-12-24 1987-10-28 Marion Laboratories Inc Use of synthetic sulfated saccharides to enhance wound healing
AU607690B2 (en) 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5908836A (en) * 1987-12-21 1999-06-01 Bar-Shalom; Daniel Protecting skin from radiation damage using sulphated sugars
DK191889D0 (da) * 1989-04-20 1989-04-20 Bukh Meditec Kosmetisk middel
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
FR2646604B1 (fr) 1989-05-03 1994-02-04 Fabre Medicament Pierre Composition pour usage externe a base de sucralfate et son procede de preparation
DK86492D0 (da) 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
US20090215717A1 (en) * 2004-08-05 2009-08-27 Ivax Drug Research Institute Ltd. Sulfated oligosaccharides
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
FR2953522A1 (fr) 2011-06-10
AR079312A1 (es) 2012-01-18
JP2013512938A (ja) 2013-04-18
US20120245120A1 (en) 2012-09-27
EP2509989A1 (fr) 2012-10-17
WO2011069921A9 (fr) 2011-09-15
WO2011069921A1 (fr) 2011-06-16
TW201127388A (en) 2011-08-16

Similar Documents

Publication Publication Date Title
FR2949470B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2963007B1 (fr) Derives anticancereux, leur preparation et leur application therapeutique
FR2959229B1 (fr) Derives peptidiques, leur preparation et leurs utilisations
DK3360575T3 (da) Transdermale farmaceutiske sammensætninger omfattende aktive stoffer
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
FR2953520B1 (fr) Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
ZA201209145B (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
BRPI1014160A2 (pt) Formulações de nanopartículas e aplicações das mesmas
IL245328A0 (en) Pharmaceutical composition
EP2550954A4 (fr) Composition de type vaseline, et préparation cosmétique
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
EP2542221A4 (fr) Formulations concentrées de protéine et leurs utilisations
SMT201700547T1 (it) Coniugati di farmaco anticorpo umano contro il fattore tissutale
BR112013015592A2 (pt) dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
FR2953522B1 (fr) Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
EP2578596A4 (fr) Levocarrimycine, ses compositions pharmaceutiques, ses procédés de préparation et ses utilisations
FR2952934B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
EP2251006A4 (fr) Microparticules et leurs compositions pharmaceutiques
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
FR2943669B1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI1010243A2 (pt) derivados de benzotiazinas, preparação dos mesmos e aplicação dos mesmos como fármacos
BRPI1014904A2 (pt) derivados de quinazolinadiona, preparação dos mesmos e vários usos terapêuticos dos mesmos.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831